Clinical Topics
News
New MS criteria may create more false positives
News
Treatment of relapsing progressive MS may reduce disability progression
A subset of MS patients with inflammatory relapse showed less risk of progression with disease-modifying therapy.
Article
Investigators Describe the MS Prodrome
The prodrome of multiple sclerosis (MS) may include an increased risk of nervous system, sensory, and musculoskeletal disorders, according to...
News
Research supports cannabis in MS, but legal, clinical pictures are murky
Video
Focus on preventing comorbidities in MS, physician urges
NASHVILLE, TENN. – It’s a kind of ‘lifestyle disease’ since other conditions can worsen it, Dr. Allen C. Bowling says, so healthier living is...
Video
New guidelines for gadolinium-based contrast agents take conservative stance
NASHVILLE, TENN. – The agents remain necessary in initial diagnosis and other specific clinical scenarios.
Video
VIDEO: PML prevention is possible, even when treating patients with aggressive MS
NASHVILLE, TENN. – Short treatment periods with natalizumab are possible for patients with aggressive disease, even with JC virus antibody...
Conference Coverage
Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatment
CARE-MS II extension data suggest that alemtuzumab provides a unique treatment approach for relapsing-remitting multiple sclerosis patients with...
Video
Pediatric MS gets a win with fingolimod
NASHVILLE, TENN. – First successful phase 3 study in pediatric MS may lead to a reshaping of the pediatric MS treatment paradigm.
Video
Inside the complex, surprising world of MS comorbidities
Research suggests some conditions are more common in MS. Cancer is an outlier: Its rates may actually be lower than in the general population.